I just got this off Biotron's web page for those who are interested in where we are at and up to.
https://www.biotron.com.au/technology/clinical-trials/Completed Human Clinical Trials:
- BIT225-001 – Phase 1, single-dose, dose escalating study (n=48)
- BIT225-003 – Phase 1b, HCV-infected patients (n=18)
- BIT225-004 – Phase 1b/2a, HIV-1 infected patients (n=21) Trial registration on ANZCTR
- BIT225-005 – Phase 2a, HCV-infected patients (n=24) Trial registration on ANZCTR
- BIT225-006 – Phase 2, HIV/HCV co-infected (n=12) Trial registration on ANZCTR
- BIT225-007 – Phase 1 capsule formulation, cross-over study (n=14) Trial registration on ANZCTR
- BIT225-008 – Phase 2, repeat dose (n=60) Trial registration on ANZCTR
Partnership and or Licensing, page-8
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $7.664K | 403.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1202498 | 5 |
View Market Depth
| Last trade - 13.42pm 27/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |